KITS π Kits Eyecare - Overview
Exchange: TO β’ Country: Canada β’ Currency: CAD β’ Type: Common Stock β’ ISIN: CA49804N1042
KITS: Eyeglasses, Contact Lenses, Frames, Progressive Lenses
Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada. Web URL: https://www.kits.com
Additional Sources for KITS Stock
KITS Stock Overview
Market Cap in USD | 185m |
Sector | Consumer Cyclical |
Industry | Specialty Retail |
GiC Sub-Industry | Other Specialty Retail |
IPO / Inception |
KITS Stock Ratings
Growth 5y | 16.0% |
Fundamental | 17.8% |
Dividend | - |
Rel. Strength Industry | 39.5 |
Analysts | - |
Fair Price Momentum | 7.40 CAD |
Fair Price DCF | 4.18 CAD |
KITS Dividends
No Dividends PaidKITS Growth Ratios
Growth Correlation 3m | -93.3% |
Growth Correlation 12m | 75.6% |
Growth Correlation 5y | 40.1% |
CAGR 5y | -2.22% |
CAGR/Mean DD 5y | -0.05 |
Sharpe Ratio 12m | 0.79 |
Alpha | 25.16 |
Beta | 0.24 |
Volatility | 39.20% |
Current Volume | 11.9k |
Average Volume 20d | 17.2k |
What is the price of KITS stocks?
As of January 03, 2025, the stock is trading at CAD 8.30 with a total of 11,872 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -7.26%, over three months by -17.90% and over the past year by +36.29%.
As of January 03, 2025, the stock is trading at CAD 8.30 with a total of 11,872 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -7.26%, over three months by -17.90% and over the past year by +36.29%.
Is Kits Eyecare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Kits Eyecare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KITS as of January 2025 is 7.40. This means that KITS is currently overvalued and has a potential downside of -10.84%.
Neither. Based on ValueRay Fundamental Analyses, Kits Eyecare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 17.80 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KITS as of January 2025 is 7.40. This means that KITS is currently overvalued and has a potential downside of -10.84%.
Is KITS a buy, sell or hold?
Kits Eyecare has no consensus analysts rating.
Kits Eyecare has no consensus analysts rating.
What are the forecast for KITS stock price target?
According to ValueRays Forecast Model, KITS Kits Eyecare will be worth about 8 in January 2026. The stock is currently trading at 8.30. This means that the stock has a potential downside of -3.37%.
According to ValueRays Forecast Model, KITS Kits Eyecare will be worth about 8 in January 2026. The stock is currently trading at 8.30. This means that the stock has a potential downside of -3.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 15.5 | 86.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 8 | -3.4% |